Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BBB Foods | TBBB | Jan 13, 2025 | 30.12 | -2.78 |
BCB Bank | BCBP | Jan 13, 2025 | 11.01 | +0.46 |
BCE | BCE | Jan 13, 2025 | 23.21 | +1.09 |
Beachbody A | BODI | Jan 13, 2025 | 6.20 | -4.62 |
Beacon Roofing Supply | BECN | Jan 13, 2025 | 105.44 | +3.27 |
Beam Global | BEEM | Jan 13, 2025 | 3.12 | -6.59 |
Beam Therapeutics | BEAM | Jan 13, 2025 | 25.54 | -3.22 |
Beamr Imaging | BMR | Jan 13, 2025 | 3.64 | -6.19 |
Beasley Broadcast A | BBGI | Jan 13, 2025 | 8.64 | -9.91 |
Beazer Homes USA | BZH | Jan 13, 2025 | 26.12 | +1.91 |
Becton, Dickinson And Co | BDX | Jan 13, 2025 | 236.19 | +1.08 |
BeiGene ADR | ONC | Jan 13, 2025 | 184.61 | +4.47 |
Bel Fuse A | BELFA | Jan 13, 2025 | 83.50 | -0.19 |
Bel Fuse B | BELFB | Jan 13, 2025 | 76.59 | -0.97 |
Belden | BDC | Jan 13, 2025 | 114.06 | +0.31 |
Belgium Investable Mkt Idx MSCI Ishares | EWK | Jan 13, 2025 | 17.90 | -0.22 |
Belite Bio ADR | BLTE | Jan 13, 2025 | 55.56 | +0.16 |
Bellevue Life Sciences Acquisition | BLAC | Jan 13, 2025 | 11.35 | 0.00 |
Bellevue Life Sciences Acquisition Unit | BLACU | Jan 13, 2025 | 11.89 | 0.00 |
BellRing Brands | BRBR | Jan 13, 2025 | 71.57 | +0.79 |
Belpointe Prep A | OZ | Jan 13, 2025 | 62.55 | -2.64 |
Benchmark Electronics | BHE | Jan 13, 2025 | 45.63 | +0.55 |
Beneficient A | BENF | Jan 13, 2025 | 0.67 | -2.01 |
Benitec Biopharma | BNTC | Jan 13, 2025 | 10.39 | -5.55 |
Benson Hill | BHIL | Jan 13, 2025 | 1.70 | -17.07 |
Bentley Systems B | BSY | Jan 13, 2025 | 45.36 | -1.09 |
Berkshire Hathaway A | BRK-A | Jan 13, 2025 | 666 280.00 | +0.49 |
Berkshire Hathaway B | BRK-B | Jan 13, 2025 | 443.91 | +0.28 |
Berkshire Hills Bancorp | BHLB | Jan 13, 2025 | 27.47 | +0.77 |
Berry | BRY | Jan 13, 2025 | 4.82 | +1.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.